NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Mammalian & mAbs

2 min read

AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars

July 28, 2026 at 6:00 AM
Mammalian & mAbs Press Release Business Updates
Read press release

2 min read

AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services

June 30, 2026 at 9:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
AGC Biologics and Novelty Nobility leaders meet to discuss GMP manufacturing of bispecific drug candidate, NN4101 in Tokyo, Japan on April 13, 2026.

2 min read

Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate

May 3, 2026 at 4:45 PM
Mammalian & mAbs Press Release Cell Line Development
Read press release

2 min read

AGC Biologics Seattle site now certified to manufacture biologics for largest pharmaceutical market in South America

February 3, 2026 at 8:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release

3 min read

AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development

December 2, 2025 at 6:00 AM
Mammalian & mAbs Press Release Business Updates Cell Line Development
Read press release
Seattle site team member hard at work

2 min read

Seattle Facility Achieves Regulatory Approvals, Customer Satisfaction and Zero-Finding ISO Certification Inspection

September 10, 2025 at 8:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
AGC Bio Seattle and Chiba site buildings

1 min read

From Seattle to Chiba: Okayama University Taps AGC Biologics' Global Pathway for New Therapeutic

July 16, 2025 at 5:00 PM
Mammalian & mAbs Press Release
Read press release
AGC Biologics to support Novelty Nobility for antibody drug candidate

2 min read

AGC Biologics Partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate

May 5, 2025 at 4:00 PM
Mammalian & mAbs Press Release
Read press release
AGC Biologics Yokohama Facility begins GMP production in 2027

2 min read

AGC Biologics Strengthens Single-Use Technology Network, Adds 5,000 L Vessels from Thermo Scientific to New Yokohama, Japan Facility

April 7, 2025 at 3:51 PM
Mammalian & mAbs Press Release
Read press release

1 min read

AGC Biologics Honored at CDMO Leadership Awards for Excellence in Quality, Biologics and Cell and Gene Therapies

March 10, 2025 at 2:41 PM
Cell & Gene Therapy Mammalian & mAbs Press Release Microbial
Read press release
1 2 3 Next